These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8659889)

  • 1. Production of a malaria transmission-blocking protein from recombinant yeast.
    Wang MY; Kaslow DC; Shiloach J
    Ann N Y Acad Sci; 1996 May; 782():123-32. PubMed ID: 8659889
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of an ethanol sensor for feedback control of growth and expression of TBV25H in Saccharomyces cerevisiae.
    Noronha SB; Wagner LW; Matheson NH; Shiloach J
    Biotechnol Bioeng; 1999 May; 63(3):285-9. PubMed ID: 10099607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials.
    Zou L; Miles AP; Wang J; Stowers AW
    Vaccine; 2003 Apr; 21(15):1650-7. PubMed ID: 12639486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein expression in yeast as an approach to production of recombinant malaria antigens.
    Bathurst IC
    Am J Trop Med Hyg; 1994; 50(4 Suppl):20-6. PubMed ID: 8172328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris.
    Tsai CW; Duggan PF; Shimp RL; Miller LH; Narum DL
    J Biotechnol; 2006 Feb; 121(4):458-70. PubMed ID: 16274825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream processing of a plant-derived malaria transmission-blocking vaccine candidate.
    Menzel S; Holland T; Boes A; Spiegel H; Fischer R; Buyel JF
    Protein Expr Purif; 2018 Dec; 152():122-130. PubMed ID: 30059744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii.
    Jones CS; Luong T; Hannon M; Tran M; Gregory JA; Shen Z; Briggs SP; Mayfield SP
    Appl Microbiol Biotechnol; 2013 Mar; 97(5):1987-95. PubMed ID: 22592550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris.
    Faber BW; Remarque EJ; Kocken CH; Cheront P; Cingolani D; Xhonneux F; Jurado M; Haumont M; Jepsen S; Leroy O; Thomas AW
    Vaccine; 2008 Nov; 26(48):6143-50. PubMed ID: 18804135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of recombinant PvDBPII, receptor binding domain of Plasmodium vivax Duffy binding protein, and evaluation of immunogenicity to identify an adjuvant formulation for vaccine development.
    Bhardwaj R; Shakri AR; Hans D; Gupta P; Fernandez-Becerra C; Del Portillo HA; Pandey G; Chitnis CE
    Protein Expr Purif; 2017 Aug; 136():52-57. PubMed ID: 26578115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient approach to the production of vaccines against the malaria parasite.
    Tsuboi T; Takeo S; Sawasaki T; Torii M; Endo Y
    Methods Mol Biol; 2010; 607():73-83. PubMed ID: 20204850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates.
    Lee SM; Wu CK; Plieskatt J; McAdams DH; Miura K; Ockenhouse C; King CR
    Malar J; 2016 Aug; 15(1):405. PubMed ID: 27515826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.
    Milek RL; DeVries AA; Roeffen WF; Stunnenberg H; Rottier PJ; Konings RN
    Exp Parasitol; 1998 Oct; 90(2):165-74. PubMed ID: 9769246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cloning, expression and identification of gametocyte specific protein Pfgdv1 of Plasmodium falciparum].
    Su PP; Meng LW; Li JY; Tao ZY; Chen Y; Qiao JC; Wu XX; Jin Y; Wang HP; Fang Q; Wang XM; Xia H
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Feb; 28(1):34-8. PubMed ID: 27356402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a multi-stage, multi-subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites.
    Spiegel H; Schinkel H; Kastilan R; Dahm P; Boes A; Scheuermayer M; Chudobová I; Maskus D; Fendel R; Schillberg S; Reimann A; Fischer R
    Biotechnol Bioeng; 2015 Apr; 112(4):659-67. PubMed ID: 25335451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
    Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
    J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
    Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
    Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes.
    Chen Q; Pettersson F; Vogt AM; Schmidt B; Ahuja S; Liljeström P; Wahlgren M
    Vaccine; 2004 Jul; 22(21-22):2701-12. PubMed ID: 15246600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficient production of recombinant DNA proteins in Saccharomyces cerevisiae by controlled high-cell-density fermentation.
    Alberghina L; Porro D; Martegani E; Ranzi BM
    Biotechnol Appl Biochem; 1991 Aug; 14(1):82-92. PubMed ID: 1910586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physarum polymalic acid hydrolase: Recombinant expression and enzyme activation.
    Mueller W; Haindl M; Holler E
    Biochem Biophys Res Commun; 2008 Dec; 377(3):735-40. PubMed ID: 18845127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.